Skip to main content
Premium Trial:

Request an Annual Quote

Incyte, Amersham Partner to Provide Genomic Data for Microarray Research

Premium

Genomic database company Incyte Genomics of Palo Alto, Calif., and Amersham Pharmacia Biotech of Sunnyvale, Calif., recently announced an alliance to provide scientists with genomic content for microarray research.

Under the terms of the non-exclusive agreement, Amersham Pharmacia Biotech will be the first company to offer Incyte’s Easy-to-Spot pre-assembled set of non-proprietary human and mouse clones. Amersham Pharmacia Biotech will offer the sequences in a format customized for the company’s Generation III microarray products.

The financial terms of the deal were not disclosed.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.